38.77
-0.77
(-1.95%)
At close: January 31 at 4:00:02 PM EST
38.77
0.00
(0.00%)
After hours: January 31 at 4:20:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 305,331 | 16 |
| Sales | 9,403,406 | 14 |
| Net Shares Purchased (Sold) | -9,098,075 | 30 |
| Total Insider Shares Held | 6.63M | -- |
| % Net Shares Purchased (Sold) | -57.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| KAPADIA SANDIP S. Chief Financial Officer | Sale at price 38.05 per share. | Direct | 67,547 | Jan 27, 2025 |
| DIERKS JEFFREY G Officer | Sale at price 36.94 - 38.02 per share. | Direct | 551,575 | Jan 27, 2025 |
| DAYNO JEFFREY M Chief Executive Officer | -- | Direct | -- | Jan 24, 2025 |
| KAPADIA SANDIP S. Chief Financial Officer | -- | Direct | -- | Jan 24, 2025 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 30.69 per share. | Direct | 402,806 | Jan 24, 2025 |
| SERAFIN ANDREW Officer | -- | Direct | -- | Jan 24, 2025 |
| BUDUR KUMAR Officer | -- | Direct | -- | Jan 24, 2025 |
| DAYNO JEFFREY M Chief Executive Officer | Sale at price 40.13 per share. | Direct | 774,245 | Jan 21, 2025 |
| KAPADIA SANDIP S. Chief Financial Officer | Sale at price 40.18 per share. | Direct | 1,004,598 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer | Sale at price 37.41 - 40.00 per share. | Direct | 1,147,715 | Jan 21, 2025 |
| DAYNO JEFFREY M Chief Executive Officer | Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 158,588 | Jan 21, 2025 |
| KAPADIA SANDIP S. Chief Financial Officer | Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 725,750 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 1,023,197 | Jan 21, 2025 |
| DIERKS JEFFREY G Officer | Sale at price 37.01 per share. | Direct | 388,841 | Jan 15, 2025 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 351,354 | Jan 15, 2025 |
| DIERKS JEFFREY G Officer | Sale at price 37.04 per share. | Direct | 265,946 | Jan 13, 2025 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 33.44 per share. | Direct | 240,099 | Jan 13, 2025 |
| MARSHMAN FUND TRUST II Beneficial Owner of more than 10% of a Class of Security | Sale at price 30.30 per share. | Direct | 139,391,500 | Nov 5, 2024 |
| VALOR IV PHARMA HOLDINGS L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale at price 30.30 per share. | Direct | 139,391,500 | Nov 5, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 40.47 per share. | Direct | 870,018 | Oct 29, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 24.00 per share. | Direct | 515,904 | Oct 29, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 35.05 - 35.62 per share. | Direct | 1,274,547 | Oct 3, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 40.19 per share. | Direct | 16,077 | Oct 1, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 24.00 per share. | Direct | 9,600 | Oct 1, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 40.03 per share. | Direct | 1,434,951 | Sep 30, 2024 |
| KAPADIA SANDIP S. Chief Financial Officer | -- | Direct | -- | Sep 30, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 24.00 per share. | Direct | 860,304 | Sep 30, 2024 |
| DIERKS JEFFREY G Officer | -- | Direct | -- | Sep 30, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 40.04 per share. | Direct | 8,009 | Sep 27, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 24.00 per share. | Direct | 4,800 | Sep 27, 2024 |
| KAPADIA SANDIP S. Chief Financial Officer | -- | Direct | -- | Mar 28, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 32.00 per share. | Direct | 383,328 | Mar 15, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 98,467 | Mar 15, 2024 |
| DIERKS JEFFREY G Officer | Sale at price 32.00 per share. | Direct | 6,208 | Mar 8, 2024 |
| DIERKS JEFFREY G Officer | Conversion of Exercise of derivative security at price 8.22 per share. | Direct | 1,595 | Mar 8, 2024 |
| KAPADIA SANDIP S. Chief Financial Officer | -- | Direct | -- | Mar 29, 2023 |
Related Tickers
CPRX Catalyst Pharmaceuticals, Inc.
22.56
-2.72%
TRDA Entrada Therapeutics, Inc.
13.44
+0.52%
HALO Halozyme Therapeutics, Inc.
56.64
+0.39%
BMRN BioMarin Pharmaceutical Inc.
63.36
-0.81%
KRYS Krystal Biotech, Inc.
159.74
+2.35%
GMAB Genmab A/S
19.67
-0.71%
MIRM Mirum Pharmaceuticals, Inc.
48.88
+0.91%
EXEL Exelixis, Inc.
33.15
+0.67%
UTHR United Therapeutics Corporation
351.17
-0.32%
CORT Corcept Therapeutics Incorporated
66.92
-4.26%